For oral semaglutide, check for changes in tablet appearance, unusual odors, or crumbling
The eligibility requirements for filing a gastroparesis claim consist of: Documented use of Ozempic, Wegovy, Rybelsus, Mounjaro, or other GLP-1 receptor agonists with prescription records or pharmacy documentation Gastroparesis diagnosis or related gastrointestinal condition (ileus, intestinal obstruction, gastric outlet obstruction) from a healthcare provider Symptoms occurring during drug use or within 30-60 days of discontinuation Medical intervention demonstrating injury severity: emergency room visits, hospitalization for at least 24 hours, or gastroenterologist consultation Persistent symptoms lasting four weeks or longer, particularly cyclic vomiting episodes No prior history of gastroparesis, gastric surgery (bypass, banding, sleeve), or conditions causing similar symptoms Medical records documenting treatment attempts and ongoing symptom management Cases filed within applicable statute of limitations (typically 1-3 years from injury discovery) The ongoing legal debate regarding diagnostic testing requirements impacts case eligibility determinations
Yes, having an underactive thyroid (hypothyroidism) is not a contraindication for GLP-1 medications like Wegovy or Ozempic
If symptoms persist beyond the early titration period, temporary dose stabilization or dose reduction should be considered
A.EdwardsC
Curcumin has been shown to improve insulin sensitivity
